![]() |
Volumn 51, Issue 46, 2015, Pages 9499-9502
|
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
APTAMER;
DNA;
DOXORUBICIN;
LOCKED NUCLEIC ACID;
PACLITAXEL;
RNV66;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
GUANINE;
OLIGONUCLEOTIDE;
RNV66 DNA APTAMER;
VASCULOTROPIN A;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BREAST CANCER;
BREAST CANCER CELL LINE;
CANCER INHIBITION;
CELL PROLIFERATION;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MOLECULAR DOCKING;
MOLECULAR DYNAMICS;
MOUSE;
NONHUMAN;
ANIMAL;
BREAST NEOPLASMS;
CELL MOTION;
CHEMISTRY;
DRUG EFFECTS;
FEMALE;
METABOLISM;
NUDE MOUSE;
PATHOLOGY;
TUMOR CELL LINE;
TUMOR VOLUME;
UMBILICAL VEIN ENDOTHELIAL CELL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APTAMERS, NUCLEOTIDE;
BREAST NEOPLASMS;
CELL LINE, TUMOR;
CELL MOVEMENT;
CELL PROLIFERATION;
FEMALE;
GUANINE;
HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS;
HUMANS;
MICE, NUDE;
MOLECULAR DOCKING SIMULATION;
MOLECULAR DYNAMICS SIMULATION;
OLIGONUCLEOTIDES;
TUMOR BURDEN;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 84930216213
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c5cc02756j Document Type: Article |
Times cited : (50)
|
References (30)
|